1.Acute Urticaria Induced by Oral Methylprednisolone.
Eun Jung JANG ; Hyun Jung JIN ; Young Hee NAM ; Joo Hee KIM ; Young Min YE ; Hae Sim PARK
Allergy, Asthma & Immunology Research 2011;3(4):277-279
Although corticosteroids have immunosuppressive, anti-inflammatory, and anti-allergic effects, allergic reactions are rare. We report a case involving a 52-year-old-female with acute urticaria caused by oral methylprednisolone. The patient had experienced aspirin-exacerbated respiratory disease (AERD) for 13 years with frequent asthma exacerbations. Symptoms of asthma exacerbations improved with short-term treatments of systemic steroids, including methylprednisolone or deflazacort, which had been well tolerated. However, the current admission was prompted by the development of acute generalized urticaria following the oral ingestion of methylprednisolone (8 mg) for relief of symptoms. An oral provocation test with 4 mg oral methylprednisolone led to generalized urticaria 20 minutes later, confirming the causal association. This is the first report of acute urticaria caused by oral methylprednisolone in a patient with AERD.
Adrenal Cortex Hormones
;
Asthma
;
Drug Hypersensitivity
;
Eating
;
Humans
;
Hypersensitivity
;
Methylprednisolone
;
Pregnenediones
;
Steroids
;
Urticaria
2.Polymorphisms of Aspirin-Metabolizing Enzymes CYP2C9, NAT2 and UGT1A6 in Aspirin-Intolerant Urticaria.
Nami Shrestha PALIKHE ; Seung Hyun KIM ; Young Hee NAM ; Young Min YE ; Hae Sim PARK
Allergy, Asthma & Immunology Research 2011;3(4):273-276
Acetyl salicylic acid (ASA) is metabolized by UDP-glucuronosyltransferase 1A6 (UGT1A6), cytochrome P4502C9 (CYP2C9), and N-acetyl transferase 2 (NAT2). Variations in the activities of these enzymes may modulate adverse ASA-related symptoms such as urticaria. We examined whether polymorphisms in the UGT1A6, CYP2C9, and NAT2 genes are related to ASA-intolerant urticaria (AIU). The genotypes of 148 subjects with AIU (AIU group) and 260 normal healthy control subjects (NC group) were analyzed with respect to the following single nucleotide polymorphisms: CYP2C9 -1188T>C and CYP2C9*3A1075C; UGT1A6 T181A A>G and UGT1A6 R184S A>C; and NAT2 9796A>T, NAT2 197G>A, NAT2 286G>A, NAT2 9601A>G, and NAT2 9306A>G. There were significant differences in the allele frequencies for the CYP2C9 polymorphisms between the two groups. The frequency of the minor allele CYP2C9 -1188T>C was significantly higher in the AIU group than in the NC group (P=0.005). The frequency of the variant genotype CC was higher in the AIU group compared with the controls in both the co-dominant (P=0.007) and recessive models (P=0.012). The frequency of haplotype 2 [CA] was also significantly higher in the AIU group in both the co-dominant (P=0.006) and dominant models (P=0.012). There was no significant difference in genotype frequencies for any of the UGT1A6 or NAT2 polymorphisms between the two groups. Clinical parameters did not differ according to genotype. These results suggest that the C allele of CYP2C9 -1188T>C may be associated with AIU.
Alleles
;
Aspirin
;
Cytochromes
;
Gene Frequency
;
Genotype
;
Haplotypes
;
Idoxuridine
;
Salicylic Acid
;
Transferases
;
Urticaria
3.Asthma-Predictive Genetic Markers in Gene Expression Profiling of Peripheral Blood Mononuclear Cells.
Seung Woo SHIN ; Tae Jeong OH ; Se Min PARK ; Jong Sook PARK ; An Soo JANG ; Sung Woo PARK ; Soo Taek UH ; Sungwhan AN ; Choon Sik PARK
Allergy, Asthma & Immunology Research 2011;3(4):265-272
PURPOSE: We sought to identify asthma-related genes and to examine the potential of these genes to predict asthma, based on expression levels. METHODS: The subjects were 42 asthmatics and 10 normal healthy controls. PBMC RNA was subjected to microarray analysis using a 35K array; t-tests were used to identify genes that were expressed differentially between the two groups. A multiple logistic regression analysis was applied to the differentially expressed genes, and area under the curve (AUC) values from receiver operating characteristic (ROC) curves were obtained. RESULTS: In total, 170 genes were selected using the following criteria: P< or =0.001 and > or =2-fold change. Among these genes, 57 were up-regulated and 113 were down-regulated in asthmatics versus normal controls. A multiple logistic regression analysis was done using more stringent criteria (P< or =0.001 and > or =5-fold change), and eight genes were selected as candidate asthma biomarkers. Using these genes, 255 models (2(8)-1) were generated. Among them, only 85 showed P< or =0.05 by multiple logistic regression analysis. Based on the AUCs from ROC curves for the 85 models, we found that the best model consisted of the genes MEPE, MLSTD1, and TRIM37. The model showed 0.9928 of the AUC with 98% sensitivity and 80% specificity. CONCLUSIONS: MEPE, MLSTD1, and TRIM37 may be useful biomarkers for asthma.
Area Under Curve
;
Asthma
;
Biomarkers
;
Gene Expression
;
Gene Expression Profiling
;
Genetic Markers
;
Logistic Models
;
Microarray Analysis
;
RNA
;
ROC Curve
4.Diagnostic Value of Clinical Parameters in the Prediction of Aspirin-Exacerbated Respiratory Disease in Asthma.
Hun Soo CHANG ; Jong Sook PARK ; An Soo JANG ; Sung Woo PARK ; Soo Taek UH ; Young Hoon KIM ; Choon Sik PARK
Allergy, Asthma & Immunology Research 2011;3(4):256-264
PURPOSE: Aspirin-exacerbated respiratory disease (AERD) has attracted a great deal of attention because of its association with increased asthma severity. However, oral aspirin challenge (OAC) to diagnose AERD is a time-consuming procedure, and some patients experience serious complications. Thus, we evaluated diagnostic values of non-invasive clinical parameters to predict AERD in asthmatic patients. METHODS: A total of 836 Korean subjects were recruited from an asthma cohort. They underwent OAC, and clinical parameters including the history of aspirin hypersensitivity, nasal polyposis, and chronic sinusitis of aspirin-tolerant asthma (ATA) and AERD asthmatic patients were compared. RESULTS: Significant differences (P<0.01) were found in eight parameters: age at diagnosis, body mass index, FEV1%, PC20, history of urticaria, nasal polyps, chronic sinusitis, and history of aspirin hypersensitivity. After logistic regression analysis based on the eight clinical parameters, nasal polyps, history of aspirin intolerance, sinusitis, and log [PC20 methacholine] remained significantly associated with AERD (P<0.05). The sensitivity and specificity of the history of aspirin hypersensitivity to predict AERD were 64.7% and 92.0%, respectively, and the positive and negative predictive values were 56.9% and 94.1%, respectively. Overall, the accuracy of the test was 88.2%. The accuracy of the tests for nasal polyps and chronic sinusitis were 67.3% and 60.4%, respectively. CONCLUSIONS: Among clinical parameters associated with AERD, the history of aspirin hypersensitivity has the best positive and negative predictive values for the oral aspirin challenge test. Because the false-positive and -negative rates were still high, additional non-invasive methods are needed to reduce the rate of false outcomes.
Aspirin
;
Asthma
;
Body Mass Index
;
Cohort Studies
;
Humans
;
Hypersensitivity
;
Logistic Models
;
Nasal Polyps
;
Sinusitis
;
Urticaria
5.The Relationship Between Serum 25 Hydroxy Vitamin D Levels and Asthma in Children.
Soheila ALYASIN ; Tooba MOMEN ; Sara KASHEF ; Abbass ALIPOUR ; Reza AMIN
Allergy, Asthma & Immunology Research 2011;3(4):251-255
PURPOSE: Asthma and other allergic disorders have increased over the past decades in nearly all nations. Many studies have suggested the role of vitamin D deficiency in both T-helper1 and T-helper2 diseases; however, the association between vitamin D, allergy, and asthma remains uncertain. In this study, the associations of 25-hydroxy vitamin D3 levels with asthma and with the severity of asthma were evaluated. METHODS: This cross-sectional study was conducted on 50 asthmatic children and 50 healthy controls aged 6-18 years. Serum 25-hydroxy vitamin D3 levels were determined and compared between the two groups. The relationship between serum vitamin D levels and pulmonary function test outcomes and eosinophil counts were examined in asthmatic patients. RESULTS: Univariate analysis of the relationship between asthma and vitamin D showed that decreased vitamin D levels were associated with significantly increased odds of asthmatic state (P=0.002). In a multivariate analysis after adjustment for age, body mass index, and sex, the relationship between vitamin D and asthma increased. In asthmatic patients, 25-hydroxy vitamin D levels had direct and significant correlations with both predicted FEV1 (R2=0.318; P=0.024) and FEV1/FVC (R2=0.315; P=0.026). There were no associations between vitamin D level and eosinophil counts, duration of disease, and the number of hospitalization or unscheduled visits in the previous year (P>0.05). CONCLUSIONS: These results showed that serum 25-hydroxy vitamin D levels were inversely associated with asthma, and there was a direct and significant relationship between vitamin D levels and pulmonary function test outcomes in asthmatic children. An interventional study in asthmatic patients with low serum vitamin D concentration may establish a causal relationship between asthma and vitamin D.
Aged
;
Asthma
;
Body Mass Index
;
Child
;
Cholecalciferol
;
Cross-Sectional Studies
;
Eosinophils
;
Hospitalization
;
Humans
;
Hypersensitivity
;
Multivariate Analysis
;
Respiratory Function Tests
;
Vitamin D
;
Vitamin D Deficiency
;
Vitamins
6.Assessment of Bronchodilator Responsiveness Following Methacholine-Induced Bronchoconstriction in Children With Asthma.
Siegfried BAUER ; Ha Neul PARK ; Hyeon Seok SEO ; Ji Eun KIM ; Dae Jin SONG ; Sang Hee PARK ; Ji Tae CHOUNG ; Young YOO ; Hyung Jin KIM
Allergy, Asthma & Immunology Research 2011;3(4):245-250
PURPOSE: The aim of this study was to investigate bronchodilator responsiveness (BDR) following methacholine-induced bronchoconstriction and to determine differences in BDR according to clinical parameters in children with asthma. METHODS: The methacholine challenge test was performed in 145 children with mild to moderate asthma, and the provocative concentration causing a 20% decline in FEV1 (PC20) was determined. Immediately after the challenge test, patients were asked to inhale short-acting beta2-agonists (SABAs) to achieve BDR, which was assessed as the change in FEV1% predictedx100/post-methacholine FEV1% predicted. For each subject, the asthma medication, blood eosinophil count, serum total IgE, serum eosinophil cationic protein level, and skin prick test result were assessed. RESULTS: The FEV1 (mean+/-SD) values of the 145 patients were 90.5+/-10.9% predicted, 64.2+/-11.5% predicted, and 86.2+/-11.2% predicted before and after methacholine inhalation, and following the administration of a SABA, respectively. The BDR did not differ significantly according to asthma medication, age, or gender. However, BDR in the atopy group (37.4+/-17.7%) was significantly higher than that in the non-atopy group (30.5+/-10.7%; P=0.037). Patients with blood eosinophilia (38.6+/-18.1%) displayed increased BDR compared with patients without eosinophilia (32.0+/-13.8%; P=0.037). CONCLUSIONS: In children with mild to moderate asthma, the responsiveness to short-acting bronchodilators after methacholine-induced bronchoconstriction was not related to asthma medication, but was higher in children with atopy and/or peripheral blood eosinophilia.
Adrenergic beta-Agonists
;
Asthma
;
Azides
;
Bronchoconstriction
;
Bronchodilator Agents
;
Child
;
Eosinophil Cationic Protein
;
Eosinophilia
;
Eosinophils
;
Humans
;
Immunoglobulin E
;
Inhalation
;
Methacholine Chloride
;
Serotonin
;
Skin
7.The Search for Genetic Variants and Epigenetics Related to Asthma.
Shin Hwa LEE ; Jong Sook PARK ; Choon Sik PARK
Allergy, Asthma & Immunology Research 2011;3(4):236-244
For the past two decades, a huge number of genetic studies have been conducted to identify the genetic variants responsible for asthma risk. Several types of genetic and genomic approaches, including linkage analysis, candidate gene single nucleotide polymorphism studies, and whole genome-wide association studies have been applied. In this review article, the results of these approaches are summarized, and their limitations are discussed. Additionally, perspectives for applying upcoming new epigenetic or genomic technologies, such as copy number variation, are introduced to increase our understanding of new omic approaches to asthma genetics.
Asthma
;
Coat Protein Complex I
;
Epigenomics
;
Genetic Association Studies
;
Genome
;
Genome-Wide Association Study
;
Polymorphism, Single Nucleotide
8.Chronic Rhinosinusitis: Therapeutic Efficacy of Anti-Inflammatory and Antibiotic Approaches.
Harsha H KARIYAWASAM ; Glenis K SCADDING
Allergy, Asthma & Immunology Research 2011;3(4):226-235
Despite the high prevalence of chronic rhinosinusitis (CRS) worldwide, the exact pathogenesis of the disease remains unknown. Even with therapeutic intervention, treatment response is often only partial and frequently ineffective. The inability to define exact disease phenotypes in relation to specific disease mechanisms has led to a broad based approach with both anti-inflammatory and anti-microbial intervention. The clinical efficacy of such current therapeutic strategies is highlighted and the urgent need for further robust therapeutic intervention studies in CRS is discussed in this article.
Clinical Trial
;
Phenotype
;
Prevalence
9.Current Control and Future Risk in Asthma Management.
Erika J SIMS ; David PRICE ; John HAUGHNEY ; Dermot RYAN ; Mike THOMAS
Allergy, Asthma & Immunology Research 2011;3(4):217-225
Despite international and national guidelines, poor asthma control remains an issue. Asthma exacerbations are costly to both the individual, and the healthcare provider. Improvements in our understanding of the therapeutic benefit of asthma therapies suggest that, in general, while long-acting bronchodilator therapy improves asthma symptoms, the anti-inflammatory activity of inhaled corticosteroids reduces acute asthma exacerbations. Studies have explored factors which could be predictive of exacerbations. A history of previous exacerbations, poor asthma control, poor inhaler technique, a history of lower respiratory tract infections, poor adherence to medication, the presence of allergic rhinitis, gastro-oesophageal reflux disease, psychological dysfunction, smoking and obesity have all been implicated as having a predictive role in the future risk of asthma exacerbation. Here we review the current literature and discuss this in the context of primary care management of asthma.
Adrenal Cortex Hormones
;
Asthma
;
Disease Progression
;
Gastroesophageal Reflux
;
Health Personnel
;
Humans
;
Nebulizers and Vaporizers
;
Obesity
;
Primary Health Care
;
Respiratory Tract Infections
;
Rhinitis
;
Rhinitis, Allergic, Perennial
;
Smoke
;
Smoking
10.Assessment of Bronchodilator Responsiveness after Methacholine-Induced Bronchoconstriction.
Allergy, Asthma & Immunology Research 2011;3(4):215-216
No abstract available.
Bronchoconstriction